Filter
288
Filtered Results: 288
Text search:
pharma
company
Featured
Recommendations
12
New Publications
77
Language
Document type
No document type
152
Studies & Reports
71
Guidelines
31
Manuals
12
Strategic & Response Plan
11
Fact sheets
4
Training Material
3
Situation Updates
3
Resource Platforms
1
Countries / Regions
South Africa
14
India
14
Kenya
13
Global
12
Zimbabwe
11
Ethiopia
11
Ghana
8
Tanzania
8
Uganda
8
Nepal
7
Sierra Leone
7
Nigeria
7
Malawi
7
Western and Central Europe
7
Philippines
6
Bangladesh
5
Namibia
5
Botswana
5
Zambia
5
Rwanda
4
Eastern Europe and Central Asia
4
Ukraine
3
Liberia
3
Myanmar / Burma
3
Lesotho
2
Benin
2
Senegal
2
Burkina Faso
2
Mongolia
2
Haiti
2
Latin America and the Carribbean
2
Eastern Europe
2
Eswatini/ Swaziland
2
North Macedonia
1
Tajikistan
1
Thailand
1
Serbia
1
China
1
Kazakhstan
1
Syria
1
Kyrgyzstan
1
Uzbekistan
1
Malaysia
1
Mozambique
1
Armenia
1
Cambodia
1
Germany
1
Congo, Democratic Republic of
1
South–East Asia Region
1
Argentina
1
Papua New Guinea
1
Russia
1
Sudan
1
Georgia
1
Mali
1
Indonesia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
164
Clinical Guidelines
20
Public Health
12
Women & Child Health
10
Pharmacy & Technologies
10
Key Resources
2
Toolboxes
Pharmacy
36
AMR
28
HIV
15
COVID-19
12
TB
10
NCDs
10
Mental Health
8
Caregiver
5
Planetary Health
4
Global Health Education
4
NTDs
3
Rapid Response
2
Refugee
2
Disability
2
Health Financing Toolbox
2
Specific Hazards
1
Conflict
1
First Revised Edition
March 2000
GOVERNMENT NOTICE | No. 192 Promulgation of Medicines and Related Substances Control Act, 2003 (Act No. 13 of 2003), of the Parliament
Accessed November, 2017
CHAPTER 244
Guidance for the preparation and submission of dossiers
CHAPTER 15:03 | Acts 14/1969, 62/1971, 35/1974, 20/1978, 41/1978 (s. 35) 39/1979, 7/1987, 11/1988, 18/1989 (s. 27), 1/1996, 6/2000, 22/2001; R.G.N. 899/1978.
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
An action research conducted in Bang Shau village Northern Shan State, Myanmar
Medicinal plants occupied an important position in the socio-cultural, spiritual and medicinal arena of rural people of India. T
The present report is based on contribution made by members of the task force and many other experts on medicinal plants. We hope the report on implementation will promot...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Int J Health Policy Manag 2017, 6(10), 587–600
Low-income countries face many contextual challenges to manage healthcare technologies effectively, as the majority are imported and resources are constrained to a greater extent. Previous healthcare technology management (HTM) policies in Benin ha...
This survey is part of a series of eight country surveys conducted in the context of the People that Deliver Initiative (peoplethatdeliver.org). This global initiative, which brings together the world’s largest organizations, aims to improve health services performance through the professionalizat...
